Market Research Firm - MarketsandMarkets offers market research reports and custom research services on 30000 high growth opportunities
Market Research, Market Size, Market Research Report, Market Share, Market Analysis, Market Growth,
Monday, June 29, 2020
Global Molecular Cytogenetics Market 2020: Developments, Challenges, and Forecast Report
Monday, June 22, 2020
High-Resolution Melting Analysis Market expected to grow at a 3.1% CAGR
The report "High Resolution-Melting Analysis Market by Product (Supermix Reagent, RT PCR Instrument, Software), Application (SNP Genotyping, Mutation Discovery, Epigenetics), Enduser (Research Laboratories, Hospital, Diagnostic Center) - Global Forecast", report provides a detailed overview of the major drivers, restraints, and threat impacting the high-resolution melting analysis market along with the estimates and forecasts of the revenue and market share analysis.
The Global High-Resolution Melting Analysis Market is expected to reach $302.1 Million, at a CAGR of 3.1% during the forecast period
Rising prevalence of infectious diseases and genetic disorders; increasing public-private investments, funds, and grants for research on genetic analysis technologies; and advantages of HRM over other genotyping technologies are the major factors driving market growth.
Download PDF (Please provide your specific interest in this report so as to help you better): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=216456020
On the basis of product & service:
The Market is segmented into instruments, reagents & consumables, and software & services. The reagents and consumables segment dominated the market in 2016; and is expected to continue to dominate the market during the forecast period. The segment is also expected to grow at the highest CAGR during the forecast period.
On the basis of application:
The High-Resolution Melting Analysis Market is broadly classified into SNP genotyping, mutation scanning, species identification, pathogen identification, epigenetics, and other applications. In 2016, the SNP genotyping segment accounted for the largest share of the Market. This can be attributed to the wide range of applications of SNP genotyping in the diagnosis of genetic and autoimmune diseases, study of the variations in drug responses, drug discovery & development, and the identification of genetic variations in plant or animal genomes.
Request Research Sample Pages:
On the basis of region:
the market is segmented into North America, Europe, Asia-Pacific, and RoW. In 2016, North America (comprising the U.S. and Canada) accounted for the largest share of the global market, followed by Europe. The rising prevalence of infectious diseases, genetic disorders, & other chronic diseases, and the large number of genotyping-based research and development projects are key growth drivers for the HRM market in North America.
Prominent Key Players in High-Resolution Melting Analysis Market:
Thermo Fisher Scientific Inc. (U.S.), F. Hofmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories (U.S.), and QIAGEN N.V. (Netherlands), Agilent Technologies Inc. (U.S.), bioMérieux S.A. (France), Illumina, Inc. (U.S.), Meridian Bioscience, Inc. (U.S.), Novacyt (France), Azura Genomics (U.S.), Canon Biomedical (U.S.), and PREMIER Biosoft (U.S.).
Monday, June 15, 2020
Viral Clearance Market 2018 Dynamics Set For Rapid Growth and Trend by 2023
According to the new market research report “Viral Clearance Market by Application (Recombinant Proteins, Blood, Vaccines), End User (Pharmaceutical & Biotechnology Companies, CROs), Method (Viral Removal (Chromatography, Nanofiltration), Viral Inactivation (Low pH)) - Global Forecast”, published by MarketsandMarkets™.
Revenue Growth of the Market:
The Global Viral Clearance Market is expected to reach $724.5 million by 2023 from USD 271.2 million in 2018, at a CAGR of 21.7% during the forecast period.
Market Segmentation:-
On the basis of application, the global market is segmented into four categories recombinant proteins, blood and blood products, vaccines, and other applications. In 2018, the recombinant proteins segment is expected to account for the largest share of the viral clearance market owing to the high potential of recombinant proteins to treat various diseases, fewer side effects, and shorter development time as compared to small molecules.
On the basis of the method, the viral clearance market is segmented into viral removal and viral inactivation. In 2018, the viral removal segment is expected to account for the largest share of the global market due to the growth in the biopharmaceutical R&D activities; the high acceptance of this method; and the accuracy, speed, and flexibility provided by the method in life sciences research
Download PDF (Please provide your specific interest in this report so as to help you better.): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=62681197
Market Growth Drivers:
- Growth in the Pharmaceutical and Biotechnology Industries
- Increasing Number of Drug Launches
- High Incidence and Large Economic Burden of Chronic Diseases
- Possibility of Cell Culture Contamination
- Advancements in Nanofiltration Technology
Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=62681197
Geographical Analysis:
The North American region is expected to account for the largest share of the market in 2018.
However, Asia Pacific is expected to witness the highest growth during the forecast period, owing to increase in generics development and manufacturing, surge in funding for medical research and the presence of a large number of CROs to provide preclinical and clinical research services in China, government initiatives to boost the use of generic drugs, increasing aging population in Japan, rise in pharmaceutical R&D expenditures in India, and the growing pharmaceutical manufacturing in Singapore and Malaysia.
Major Key Players In Global Viral Clearance Market:
Wuxi Biologics (Cayman) (China), Merck KGaA (Germany), Charles River Laboratories International Inc. (US), and Texcell Inc. (France), Kedrion (Italy), Vironova Biosafety (Sweden), Clean Cells (France), BSL BIOSERVICE Scientific Laboratories Munich GmbH (Germany), and ViruSure GmbH (Austria).
Thursday, June 4, 2020
Leukapheresis Market Size 2018, Global Industry Analysis,Share, Trends, Status and Future Forecast 2023
The major factors driving the growth of the Leukapheresis Market include the rising incidence and prevalence of leukemia, growing demand for leukopaks, and the increasing number of blood donations. Leukopaks are enriched leukapheresis products that contain higher concentrations of leukocytes.
The Leukapheresis Products Market is expected to reach USD 27.7 million, at a CAGR of 7.4%
The Leukopaks Market is expected to reach USD 445.6 million, at a CAGR of 46.4% during the forecast period.
Leukapheresis Market Major Drivers;
Increasing incidence and prevalence of leukemia;
Globally, the incidence of leukemia has risen significantly. According to the NIH National Cancer Institute in 2015, 405,815 people were suffering from leukemia in the US. According to NIH estimates, the number of new cases of leukemia has increased on an average rate of 0.3% each year over the last 10 years (from 2006 to 2015). The NIH also estimates that the number of new cases may reach 60,300 in 2018. According to the Leukemia & Lymphoma Society, from 2010 to 2014, leukemia was the sixth-most-common cause of cancer deaths globally.
Browse 134 market data Tables and 49 Figures spread through 194 Pages and in-depth TOC – Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20283148
By product, the apheresis devices segment is expected to account for the largest share of the leukapheresis devices market in 2018
On the basis of type, the leukapheresis devices market is segmented into apheresis devices, leukapheresis columns & cell separators, and leukoreduction filters. In 2017, the apheresis devices segment accounted for the largest share of the leukapheresis devices market. The large share of this segment is attributed to the widespread adoption of apheresis devices for performing therapeutic leukapheresis procedures for the treatment of leukemia and development of leukopaks for clinical and preclinical research.
By product, the mobilized PB leukopaks segment is expected to account for the largest share of the leukopaks market in 2018
On the basis of type, the leuopaks market is segmented into mobilized PB leukopaks, non-mobilized PB leukopaks, diseased leukopaks, and isolated PBMCs. The mobilized PB leukopaks segment is expected to account for the largest share of the global leukopaks market in 2018. The dominant share of this segment is attributed to the increasing demand for low-granulocyte and low-hematocrit contamination, high cell viability, and an increase in CD34+ cell frequencies for the development of immunotherapies.
Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=20283148
Asia Pacific is expected to account for the largest share of the leukapheresis market in 2018, followed by North America. The increase in regenerative medicine research in the region, growth in the number of clinical trials for CAR-T therapy, and the presence of leading pharma and biotech companies focusing on cell therapy research are factors are driving the growth of this regional segment.
The prominent players in the global leukapheresis products market are Asahi Kasei Medical (Japan), Fresenius (Germany), Haemonetics Corporation (US), Terumo BCT (US), STEMCELL Technologies (Canada), and Macopharma (France).
Some prominent players in the leukopaks market are HemaCare (US), AllCells (US), StemExpress (US), PPA Research Group (US), Key Biologics (US), Caltag Medsystem (UK), ZenBio (US), Precision for Medicine (US), and BioIVT (US).
Subscribe to:
Posts (Atom)